851 related articles for article (PubMed ID: 18398343)
21. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat.
Stragier B; Demaegdt H; De Bundel D; Smolders I; Sarre S; Vauquelin G; Ebinger G; Michotte Y; Vanderheyden P
Brain Res; 2007 Feb; 1131(1):97-105. PubMed ID: 17169335
[TBL] [Abstract][Full Text] [Related]
22. Moderate intrarenal vasoconstriction after high pressor doses of norepinephrine in the rat: comparison with effects of angiotensin II.
Badzyńska B; Sadowski J
Kidney Blood Press Res; 2011; 34(5):307-10. PubMed ID: 21606652
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats.
Rivera-Jardón FF; Castro-Moreno P; Figueroa-Guillén ES; Gallardo-Ortíz IA; Godínez-Hernández D; Ibarra-Barajas M
Proc West Pharmacol Soc; 2009; 52():47-9. PubMed ID: 22128421
[TBL] [Abstract][Full Text] [Related]
24. Fetal uninephrectomy in male sheep alters the systemic and renal responses to angiotensin II infusion and AT1R blockade.
Singh RR; Moritz KM; Wintour EM; Jefferies AJ; Iqbal J; Bertram JF; Denton KM
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F319-26. PubMed ID: 21543419
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Lew RA; Mustafa T; Ye S; McDowall SG; Chai SY; Albiston AL
J Neurochem; 2003 Jul; 86(2):344-50. PubMed ID: 12871575
[TBL] [Abstract][Full Text] [Related]
26. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M
Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208
[TBL] [Abstract][Full Text] [Related]
27. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
Banks T; Oyekan A
J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in the renal vascular response to angiotensin II involves the Mas receptor.
Safari T; Nematbakhsh M; Hilliard LM; Evans RG; Denton KM
Acta Physiol (Oxf); 2012 Oct; 206(2):150-6. PubMed ID: 22775972
[TBL] [Abstract][Full Text] [Related]
30. Intrarenal Mas and AT
O'Neill J; Healy V; Johns EJ
Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861
[TBL] [Abstract][Full Text] [Related]
31. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.
Lochard N; Thibault G; Silversides DW; Touyz RM; Reudelhuber TL
Circ Res; 2004 Jun; 94(11):1451-7. PubMed ID: 15117826
[TBL] [Abstract][Full Text] [Related]
32. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
Husková Z; Kramer HJ; Vanourková Z; Cervenka L
J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
[TBL] [Abstract][Full Text] [Related]
33. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response.
Kawada N; Dennehy K; Solis G; Modlinger P; Hamel R; Kawada JT; Aslam S; Moriyama T; Imai E; Welch WJ; Wilcox CS
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F753-9. PubMed ID: 15213069
[TBL] [Abstract][Full Text] [Related]
34. Vascular effects of COX inhibition and AT1 receptor blockade in transgenic rats harboring mouse renin-2 gene.
Cheng ZJ; Tikkanen I; Vapaatalo H; Mervaala EM
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):597-613. PubMed ID: 12512695
[TBL] [Abstract][Full Text] [Related]
35. The intrarenal renin-angiotensin system.
Burns KD; Homma T; Harris RC
Semin Nephrol; 1993 Jan; 13(1):13-30. PubMed ID: 8434183
[TBL] [Abstract][Full Text] [Related]
36. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands.
Axén A; Lindeberg G; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
J Pept Sci; 2006 Nov; 12(11):705-13. PubMed ID: 16967438
[TBL] [Abstract][Full Text] [Related]
37. The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
Zanchi A; Perregaux C; Maillard M; Cefai D; Nussberger J; Burnier M
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1228-34. PubMed ID: 16835400
[TBL] [Abstract][Full Text] [Related]
38. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
Cervenka L; Wang CT; Navar LG
Am J Physiol; 1998 May; 274(5):F940-5. PubMed ID: 9612332
[TBL] [Abstract][Full Text] [Related]
39. The CNS renin-angiotensin system.
von Bohlen und Halbach O; Albrecht D
Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
[TBL] [Abstract][Full Text] [Related]
40. Renal AT1 receptor: autoradiographic localization and quantification in rat.
Asano N; Ogura T; Mimura Y; Kishida M; Kataoka H; Otsuka F; Yamauchi T; Makino H
Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):161-70. PubMed ID: 9667070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
